Hellenic Centre for Disease Control and Prevention, Athens, Greece.
National and Kapodistrian University of Athens, Faculty of Nursing, 'P & A Kyriakou' Children's Hospital, Athens, Greece.
Euro Surveill. 2019 Jul;24(27). doi: 10.2807/1560-7917.ES.2019.24.27.1800326.
After the 2016 Balkan route border closures, vaccination of refugee children in Greece was mainly performed by non-governmental organisations. Activities varied between camps, resulting in heterogeneity of vaccination coverage (VC). In April 2017, the European programme 'PHILOS - Emergency health response to refugee crisis' took over vaccination coordination. Interventions were planned for the first time for refugee children in the community and unaccompanied minors at safe zones. From April 2017-April 2018, 57,615 vaccinations were performed against measles-mumps-rubella (MMR) (21,031), diphtheria-tetanus-pertussis (7,341), poliomyelitis (7,652), pneumococcal disease (5,938), type b (7,179) and hepatitis B (8,474). In April 2018, the vaccination status of children at camps (reception and identification centres and community facilities such as hostels/hotels were excluded) was recorded and VC for each disease, stratified by dose, nationality and camp size, was calculated. More than 80% of the children received the first MMR dose, with VC dropping to 45% for the second dose. For all other vaccines, VC was < 50% for the first dose in children aged 0-4 years and < 25% for the second dose. Despite challenges, PHILOS improved planning and monitoring of vaccination activities; however, further efforts towards improving VC in refugee children are needed.
2016 年巴尔干路线边境关闭后,希腊的难民儿童疫苗接种主要由非政府组织进行。各营地之间的活动各不相同,导致疫苗接种覆盖率(VC)存在异质性。2017 年 4 月,欧洲项目“PHILOS-难民危机紧急卫生应对”接管了疫苗接种协调工作。首次为社区中的难民儿童和无人陪伴的未成年人在安全区计划了干预措施。2017 年 4 月至 2018 年 4 月,共进行了 57615 次麻疹-腮腺炎-风疹(MMR)(21031 次)、白喉-破伤风-百日咳(7341 次)、脊髓灰质炎(7652 次)、肺炎球菌病(5938 次)、乙型流感嗜血杆菌(7179 次)和乙型肝炎(8474 次)疫苗接种。2018 年 4 月,记录了营地中儿童(不包括接待和身份识别中心以及宿舍/酒店等社区设施)的疫苗接种状况,并按剂量、国籍和营地规模对每种疾病的 VC 进行了分层计算。超过 80%的儿童接受了第一剂 MMR 疫苗,第二剂的 VC 下降到 45%。对于所有其他疫苗,0-4 岁儿童的第一剂 VC<50%,第二剂 VC<25%。尽管存在挑战,但 PHILOS 改善了疫苗接种活动的规划和监测;然而,仍需要进一步努力提高难民儿童的 VC。